Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARIPRAZINE vs CARTEOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARIPRAZINE vs CARTEOLOL: Safety Overview

Metric CARIPRAZINE CARTEOLOL
Total FAERS Reports 6,547 318
Deaths Reported 194 30
Death Rate 3.0% 9.4%
Hospitalizations 702 93
Average Patient Age 40.4 yrs 67.5 yrs
% Female Patients 64.0% 56.6%
FDA Approval Date Dec 16, 2025 Dec 28, 1988
Manufacturer Allergan, Inc. Sandoz Inc
Route ORAL OPHTHALMIC
Marketing Status Prescription Discontinued